BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38164129)

  • 1. An orally available cancer drug AZD6738 prevents type 1 diabetes.
    Sugitani N; Mason HR; Campfield BT; Piganelli JD
    Front Immunol; 2023; 14():1290058. PubMed ID: 38164129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy.
    Vendetti FP; Pandya P; Clump DA; Schamus-Haynes S; Tavakoli M; diMayorca M; Islam NM; Chang J; Delgoffe GM; Beumer JH; Bakkenist CJ
    JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36810257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment.
    Ao W; Kim HI; Tommarello D; Conrads KA; Hood BL; Litzi T; Abulez T; Teng PN; Dalgard CL; Zhang X; Wilkerson MD; Darcy KM; Tarney CM; Phippen NT; Bakkenist CJ; Maxwell GL; Conrads TP; Risinger JI; Bateman NW
    Gynecol Oncol; 2023 Oct; 177():60-71. PubMed ID: 37639904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models.
    Dunlop CR; Wallez Y; Johnson TI; Bernaldo de Quirós Fernández S; Durant ST; Cadogan EB; Lau A; Richards FM; Jodrell DI
    Br J Cancer; 2020 Oct; 123(9):1424-1436. PubMed ID: 32741974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes.
    Prasad S; Xu D; Miller SD
    Rev Diabet Stud; 2012; 9(4):319-27. PubMed ID: 23804269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
    Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
    Front Immunol; 2018; 9():290. PubMed ID: 29503651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic β Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic Mice.
    Podojil JR; Genardi S; Chiang MY; Kakade S; Neef T; Murthy T; Boyne MT; Elhofy A; Miller SD
    J Immunol; 2022 Aug; 209(3):465-475. PubMed ID: 35725270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphenol A (BPA) aggravates multiple low-dose streptozotocin-induced Type 1 diabetes in C57BL/6 mice.
    Cetkovic-Cvrlje M; Thinamany S; Bruner KA
    J Immunotoxicol; 2017 Dec; 14(1):160-168. PubMed ID: 28707492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic identification of MHC class I-associated peptidome derived from non-obese diabetic mouse thymus and pancreas.
    Wang L; Li X; Yang S; Chen X; Li J; Wang S; Zhang M; Zheng Z; Zhou J; Wang L; Wu Y
    J Proteomics; 2023 Jan; 270():104746. PubMed ID: 36210013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice.
    Filippi CM; Estes EA; Oldham JE; von Herrath MG
    J Clin Invest; 2009 Jun; 119(6):1515-23. PubMed ID: 19478458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
    Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
    J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Type 1 Diabetes with Acetalated Dextran Microparticles Containing Rapamycin and Pancreatic Peptide P31.
    Chen N; Kroger CJ; Tisch RM; Bachelder EM; Ainslie KM
    Adv Healthc Mater; 2018 Sep; 7(18):e1800341. PubMed ID: 30051618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and therapeutic control of diabetogenic CD8+ T cells.
    Santamaria P
    Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of MHC-mismatched mouse embryonic stem cell-derived thymic epithelial progenitors and MHC-matched bone marrow prevents autoimmune diabetes.
    Su M; Lin Y; He Z; Lai L
    Stem Cell Res Ther; 2019 Aug; 10(1):239. PubMed ID: 31387620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
    Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
    J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay.
    Diana J; Brezar V; Beaudoin L; Dalod M; Mellor A; Tafuri A; von Herrath M; Boitard C; Mallone R; Lehuen A
    J Exp Med; 2011 Apr; 208(4):729-45. PubMed ID: 21444661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycolysis Inhibition Induces Functional and Metabolic Exhaustion of CD4
    Martins CP; New LA; O'Connor EC; Previte DM; Cargill KR; Tse IL; Sims-Lucas S; Piganelli JD
    Front Immunol; 2021; 12():669456. PubMed ID: 34163475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
    Serreze DV; Marron MP; Dilorenzo TP
    Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
    Ly D; Mi QS; Hussain S; Delovitch TL
    J Immunol; 2006 Sep; 177(6):3695-704. PubMed ID: 16951329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Insulin Peptide Autoantigen Delivery by Mannosylated Sodium Alginate Nanoparticles Delayed but Could Not Prevent the Onset of Type 1 Diabetes in Nonobese Diabetic Mice.
    Qu Y; Shi H; Liu M; Zhang M; Wang H; Pang L; Zhang C; Kong D; Li C
    Mol Pharm; 2021 Apr; 18(4):1806-1818. PubMed ID: 33734705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.